Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel
Journal cover image

Azimilide decreases recurrent ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators.

Publication ,  Journal Article
Singer, I; Al-Khalidi, H; Niazi, I; Tchou, P; Simmons, T; Henthorn, R; Holroyde, M; Brum, J
Published in: J Am Coll Cardiol
January 7, 2004

OBJECTIVES: This study evaluated the effects of azimilide dihydrochloride (AZ) on anti-tachycardia pacing (ATP) and shock-terminated events in patients with implantable cardioverter defibrillators (ICDs). BACKGROUND: Animal studies have shown the effectiveness of AZ for therapy of supraventricular and ventricular tachycardia (VT). Azimilide dihydrochloride was investigated as adjunctive treatment for reducing the frequency of VT and, thus, the need for ICD therapies, including ATP and cardioversion/defibrillation (ICD shocks) in patients with inducible monomorphic VT. METHODS: A total of 172 patients were randomized to daily treatment with placebo, 35 mg, 75 mg, or 125 mg of oral AZ in this dose-ranging pilot study of patients with ICDs. The majority of patients had a history of documented remote myocardial infarction and congestive heart failure New York Heart Association class II or III. RESULTS: The frequency of appropriate shocks and ATP were significantly decreased among AZ-treated patients compared with placebo patients. The incidence of ICD therapies per patient-year among the placebo group was 36, and it was 10, 12, and 9 among 35 mg, 75 mg, and 125 mg AZ patients, respectively (hazard ratio = 0.31, p = 0.0001). Azimilide dihydrochloride was generally well tolerated and did not affect left ventricular ejection fraction or minimal energy requirements for defibrillation or pacing. CONCLUSIONS: Azimilide dihydrochloride may be a safe and effective drug for reducing the frequency of VT and ventricular fibrillation in patients with implanted ICDs.

Duke Scholars

Published In

J Am Coll Cardiol

DOI

ISSN

0735-1097

Publication Date

January 7, 2004

Volume

43

Issue

1

Start / End Page

39 / 43

Location

United States

Related Subject Headings

  • Tachycardia, Ventricular
  • Recurrence
  • Piperazines
  • Pilot Projects
  • Male
  • Imidazolidines
  • Imidazoles
  • Hydantoins
  • Humans
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Singer, I., Al-Khalidi, H., Niazi, I., Tchou, P., Simmons, T., Henthorn, R., … Brum, J. (2004). Azimilide decreases recurrent ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators. J Am Coll Cardiol, 43(1), 39–43. https://doi.org/10.1016/j.jacc.2003.07.033
Singer, Igor, Hussein Al-Khalidi, Imran Niazi, Patrick Tchou, Tony Simmons, Richard Henthorn, Michael Holroyde, and Jose Brum. “Azimilide decreases recurrent ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators.J Am Coll Cardiol 43, no. 1 (January 7, 2004): 39–43. https://doi.org/10.1016/j.jacc.2003.07.033.
Singer I, Al-Khalidi H, Niazi I, Tchou P, Simmons T, Henthorn R, et al. Azimilide decreases recurrent ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators. J Am Coll Cardiol. 2004 Jan 7;43(1):39–43.
Singer, Igor, et al. “Azimilide decreases recurrent ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators.J Am Coll Cardiol, vol. 43, no. 1, Jan. 2004, pp. 39–43. Pubmed, doi:10.1016/j.jacc.2003.07.033.
Singer I, Al-Khalidi H, Niazi I, Tchou P, Simmons T, Henthorn R, Holroyde M, Brum J. Azimilide decreases recurrent ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators. J Am Coll Cardiol. 2004 Jan 7;43(1):39–43.
Journal cover image

Published In

J Am Coll Cardiol

DOI

ISSN

0735-1097

Publication Date

January 7, 2004

Volume

43

Issue

1

Start / End Page

39 / 43

Location

United States

Related Subject Headings

  • Tachycardia, Ventricular
  • Recurrence
  • Piperazines
  • Pilot Projects
  • Male
  • Imidazolidines
  • Imidazoles
  • Hydantoins
  • Humans
  • Female